Founder
CurrentMongoose Bio is a TCR-T cell therapy company using epigenetically programmed memory T cells targeting first-in-class immunogenic epitopes for common and rare cancers. It is the culmination of more than 20 years of research in the Yee Lab to deliver outpatient-based cell therapy with minimal toxicities to the global cancer patient population for solid and liquid malignancies with high unmet need and the potential to expediently implement combination-based modalities.